Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milind Javle

Showing results (21-30 of 226) with videos related to

Pageof 23
Sort By:
Chinese Clinical Oncology|February 4, 2020
Interventional radiology approaches for intra-hepatic cholangiocarcinomaCristina Mosconi, Marco Calandri, Milind Javle, et al.
The Oncologist|June 30, 2023
Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant TumorsMilind Javle, Gentry King, Kristen Spencer, et al.
Expert Review of Gastroenterology & Hepatology|October 12, 2010
Cholangiocarcinoma: an endoscopist's perspectiveMuslim Atiq, Milind Javle, Shyam Dang, et al.
Oncology (Williston Park, N.Y.)|January 15, 2005
Hypersensitivity Reactions to oxaliplatin: incidence and managementAruna Gowda, Ramil Goel, Joanne Berdzik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicityTaro Okazaki, Milind Javle, Motofumi Tanaka, et al.
Anticancer Research|August 6, 2005
Chemoradiation is a tolerable therapy for older adults with esophageal cancerSujatha Nallapareddy, Gregory E Wilding, Gary Yang, et al.
Cancers|July 2, 2021
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical PracticeAnuhya Kommalapati, Sri Harsha Tella, Mitesh Borad, et al.
Hematology/Oncology Clinics of North America|June 10, 2026
Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging HorizonsJorge Adeva, Valerie S Kalluri, Fen Saj, et al.
Journal of Gastrointestinal Oncology|December 2, 2014
Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trialSidra Anwar, Wei Tan, Jinhee Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2026
Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation TherapySrinivas Cheenu Kappadath, Ahmed Kaseb, Milind Javle, et al.
Pageof 23

Showing results (21-30 of 226) with videos related to

Sort By:
Pageof 23
Chinese Clinical Oncology|February 4, 2020
Interventional radiology approaches for intra-hepatic cholangiocarcinomaCristina Mosconi, Marco Calandri, Milind Javle, et al.
The Oncologist|June 30, 2023
Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant TumorsMilind Javle, Gentry King, Kristen Spencer, et al.
Expert Review of Gastroenterology & Hepatology|October 12, 2010
Cholangiocarcinoma: an endoscopist's perspectiveMuslim Atiq, Milind Javle, Shyam Dang, et al.
Oncology (Williston Park, N.Y.)|January 15, 2005
Hypersensitivity Reactions to oxaliplatin: incidence and managementAruna Gowda, Ramil Goel, Joanne Berdzik, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicityTaro Okazaki, Milind Javle, Motofumi Tanaka, et al.
Anticancer Research|August 6, 2005
Chemoradiation is a tolerable therapy for older adults with esophageal cancerSujatha Nallapareddy, Gregory E Wilding, Gary Yang, et al.
Cancers|July 2, 2021
FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical PracticeAnuhya Kommalapati, Sri Harsha Tella, Mitesh Borad, et al.
Hematology/Oncology Clinics of North America|June 10, 2026
Molecularly Guided Therapy in Hepatobiliary Cancers: Current Standards and Emerging HorizonsJorge Adeva, Valerie S Kalluri, Fen Saj, et al.
Journal of Gastrointestinal Oncology|December 2, 2014
Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trialSidra Anwar, Wei Tan, Jinhee Yu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2026
Yttrium-90 Radioembolization Provides Durable Local Control and Definitive Radiation TherapySrinivas Cheenu Kappadath, Ahmed Kaseb, Milind Javle, et al.
Pageof 23